Each filer's latest filing for 825704109 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
First Light Asset Management, LLC
13G/A
|
18.4% |
5/7/2026
Event 4/30/2026
|
||
| First Light Asset Management, LLC | 18.0% | |||
| Mathew P. Arens | 18.4% | |||
| BlackRock, Inc. 13G/A | 8.0% |
7/30/2026
Event 6/30/2026
|
||
|
Cadian Capital Management, LP
13G
|
7.5% |
8/14/2026
Event 6/30/2026
|
||
| Cadian Capital Management, LP | 7.5% | |||
| Cadian Capital Management GP, LLC | 7.5% | |||
| Eric Bannasch | 7.5% | |||
|
American Century Investment Management, Inc.
13G/A
|
5.3% |
2/13/2026
Event 12/31/2025
|
||
| American Century Mutual Funds, Inc. | 4.1% | |||
| American Century Investment Management, Inc. | 5.3% | |||
| American Century Companies, Inc. | 5.3% | |||
| Stowers Institute for Medical Research | 5.3% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (4) | ||||
| Champlain Investment Partners, LLC 13G | 4.9% |
2/12/2026
Event 9/30/2025
|
||
|
Brown Advisory Inc
13G/A
|
4.5% |
11/13/2026
Event 9/30/2026
|
||
| Brown Advisory Inc | 4.5% | |||
| Brown Investment Advisory & Trust Co | <0.1% | |||
| Brown Advisory LLC | 4.5% | |||
| Signature Financial Management, Inc. | 0% | |||
| Brown Advisory Ltd | <0.1% | |||
|
OrbiMed Capital LLC
13G/A
|
0% |
2/17/2026
Event 12/31/2025
|
||
| OrbiMed Capital LLC | 0% | |||
| OrbiMed Advisors LLC | 0% | |||
| Vanguard Group Inc 13G/A | 0% |
3/27/2026
Event 3/13/2026
|
||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 179 | 48.6 M | $915M |
| 2026 Q2 | 169 | 47.4 M | $774M |
| 2026 Q1 | 180 | 43.4 M | $548M |
| 2025 Q4 | 184 | 41.3 M | $815M |
| 2025 Q3 | 175 | 41.9 M | $616M |
| 2025 Q2 | 179 | 40.9 M | $769M |
| 2025 Q1 | 160 | 40.5 M | $568M |
| 2024 Q4 | 145 | 39.8 M | $546M |
| 2024 Q3 | 134 | 40.7 M | $569M |
| 2024 Q2 | 139 | 40.9 M | $526M |
| 2024 Q1 | 147 | 40.8 M | $667M |
| 2023 Q4 | 156 | 39.3 M | $824M |
| 2023 Q3 | 151 | 38.9 M | $826M |
| 2023 Q2 | 170 | 37.8 M | $1.02B |
| 2023 Q1 | 119 | 33.5 M | $659M |
| 2022 Q4 | 102 | 33.6 M | $458M |
| 2022 Q3 | 111 | 33.8 M | $590M |
| 2022 Q2 | 112 | 34.4 M | $454M |
| 2022 Q1 | 114 | 32.4 M | $732M |
| 2021 Q4 | 118 | 32.4 M | $719M |
| 2021 Q3 | 125 | 31.2 M | $668M |
| 2021 Q2 | 136 | 30.6 M | $962M |
| 2021 Q1 | 137 | 29.2 M | $966M |
| 2020 Q4 | 135 | 26.3 M | $785M |
| 2020 Q3 | 98 | 21.2 M | $503M |
| 2020 Q2 | 84 | 19.2 M | $315M |
| 2020 Q1 | 82 | 18.7 M | $224M |
| 2019 Q4 | 63 | 13.9 M | $298M |
| 2019 Q3 | 67 | 12.8 M | $225M |
| 2019 Q2 | 63 | 11.2 M | $227M |
| 2019 Q1 | 45 | 9.55 M | $180M |
| 2018 Q4 | 51 | 9.60 M | $201M |